AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]
Q32 Bio has reported positive 36-week Phase 2 data showing [...]
AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]
Q32 Bio has reported positive 36-week Phase 2 data showing [...]